Abstract:A 61-year-old male presented with high-risk ACS. His LVEF was 25%, with hypokinesis of anterior and inferior walls and coronary angiography showed significant and diffuse three vessel disease, which was not amenable to percutaneous or surgical revascularization. While hospitalized, he developed cardiogenic shock and required hemodynamic support with inotropes and IABP. As a result, he underwent complex PCI to his RCA to improve his cardiac output. The PCI was successful, but his hemodynamic parameters did not change and he remained reliant on inotropic and IABP support. Whenever the IABP would be removed, he would develop flash pulmonary edema and acute renal insufficiency. His work-up for durable LVAD or heart transplantation led to several relative contraindications (severe protein-calorie malnutrition, poor insight, poor social support). so the advanced heart failure team discussion recommended ‘Bridge to Decision’ MCS therapies while those relative contraindications resolved. After two episodes of recurrent cardiogenic shock after removal of IABP, the decision was made to proceed with left axillary Impella® 5.5 insertion for semi-durable hemodynamic support that will allow for physical rehabilitation. Impella® 5.5 was inserted with gradual improvement in hemodynamic status, but he remained Inotropic and vasopressor dependent. His course was further complicated by AKI, for which he was started on continuous veno-venous hemodialysis that was gradually transitioned to intermittent hemodialysis and his renal function gradually returned to normal. At that point, weaning off of Impella® 5.5 was attempted, but he developed flash pulmonary edema and cardiogenic shock. On day 24, the Impella® 5.5 system malfunctioned, with resultant hemodynamics. Another Impella® 5.5 system was inserted via left axillary access and hemodynamic parameters improved (pulmonary edema resolved). He subsequently started ambulating and his nutritional status improved significantly. Throughout this period, the patient's mental status remained intact and he never required intubation, without any infections/sepsis, hemolysis or vascular complications. On day 83 from the original implant, and day 59 from the second implant, he underwent removal of the Impella 5.5 system with subsequent durable LVAD placement with a Heartmate III device on day 90.Our case describes the safe and effective utilization of the Impella® 5.5 temporary MCS system for a prolonged period of time (83 days), as a Bridge-to-Decision strategy.

Temporary Mechanical Circulatory Support During Bariatric Surgery: A Novel Bridge to Durable Left Ventricular Assist Device and Cardiac Transplantation

Robotic Sleeve Gastrectomy In A Patient Supported With Impella 5.5: Innovation Amongst Advanced Heart Failure Patients

Bridge to Weight Loss: A Case Series

Extending the window in clinical decision making: the role for Impella 5.5 in cardiogenic shock

Minimally Invasive Direct Aortic Implantation of Impella 5.5 As Bridge to Transplant: A Case Report

Prolonged Impella® 5.5 Utilization As A Bridge To Destination (btd) In A Patient With End-stage Heart Failure

Obesity, Challenges, and Weight-Loss Strategies for Patients With Ventricular Assist Devices

Temporary mechanical circulatory support devices: updates from recent studies

Ventricular Remodeling Following Metabolic and Bariatric Surgery Decreases Need for Heart Transplantation: A Predictive Model

Temporary Microaxial Support in a Patient With Multiple Post-Myocardial Infarction Mechanical Complications: Bridge to Transplantation

Impella 5.5 Bridge to Heart Transplant: An Institutional Series and a Closer Look at Device Removal Technique

Hemodynamic support with percutaneous devices in patients with heart failure

Minimally Invasive Off-Pump Technique for Temporary Left Ventricular Support

Structured Weaning From the Impella Left Ventricular Micro-Axial Pump in Acute Myocardial Infarction With Cardiogenic Shock and Protected Percutaneous Coronary Intervention: Experience From a Non-Cardiac Surgical Centre

Impella 5.5 as a bridge-to-surgery in acute ischemic mitral regurgitation post-percutaneous coronary intervention: a case report

Percutaneous Venopulmonary Extracorporeal Membrane Oxygenation as Bridge to Lung Transplantation

Temporary Mechanical Circulatory Support after Cardiac Surgery

TriVAD: Successful use of Impella 5.5 and Protek Duo CentriMag RVAD following Heartware HVAD thrombosis as a bridge to heart transplant

Cardiological Challenges Related to Long-Term Mechanical Circulatory Support for Advanced Heart Failure in Patients with Chronic Non-Ischemic Cardiomyopathy

Comparison of Intraoperative Blood Product Use During Heart Transplantation in Patients Bridged with Impella 5.5 versus Durable Left Ventricular Assist Devices

A second chance for a new heart? The role of metabolic and bariatric surgery in patients with end-stage heart failure